Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements
Crossref DOI link: https://doi.org/10.1007/s43441-019-00036-y
Published Online: 2020-01-06
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Freije, Ingrid
Lamouche, Stéphane
Tanguay, Mario http://orcid.org/0000-0001-5352-2871
Text and Data Mining valid from 2020-01-01
Article History
Received: 6 June 2018
Accepted: 12 October 2018
First Online: 6 January 2020
Declaration of Conflicting Interests
: No potential conflicts were declared.